211 related articles for article (PubMed ID: 19805108)
1. Orthogonal analytical approaches to detect potential contaminants in heparin.
Guerrini M; Zhang Z; Shriver Z; Naggi A; Masuko S; Langer R; Casu B; Linhardt RJ; Torri G; Sasisekharan R
Proc Natl Acad Sci U S A; 2009 Oct; 106(40):16956-61. PubMed ID: 19805108
[TBL] [Abstract][Full Text] [Related]
2. Crude Heparin Preparations Unveil the Presence of Structurally Diverse Oversulfated Contaminants.
Mendes A; Meneghetti MCZ; Palladino MV; Justo GZ; Sassaki GL; Fareed J; Lima MA; Nader HB
Molecules; 2019 Aug; 24(16):. PubMed ID: 31426507
[TBL] [Abstract][Full Text] [Related]
3. Quantitative capillary electrophoresis determination of oversulfated chondroitin sulfate as a contaminant in heparin preparations.
Volpi N; Maccari F; Linhardt RJ
Anal Biochem; 2009 May; 388(1):140-5. PubMed ID: 19232311
[TBL] [Abstract][Full Text] [Related]
4. Characterization of currently marketed heparin products: key tests for quality assurance.
Keire DA; Ye H; Trehy ML; Ye W; Kolinski RE; Westenberger BJ; Buhse LF; Nasr M; Al-Hakim A
Anal Bioanal Chem; 2011 Jan; 399(2):581-91. PubMed ID: 20680615
[TBL] [Abstract][Full Text] [Related]
5. [Capillary electrophoresis analysis of contaminants in heparin sodium for the Japanese pharmacopoeia purity test].
Kakoi N; Kinoshita M; Kawasaki N; Yamaguchi T; Hayakawa T; Kakehi K
Yakugaku Zasshi; 2009 Oct; 129(10):1255-64. PubMed ID: 19797882
[TBL] [Abstract][Full Text] [Related]
6. Analysis and characterization of heparin impurities.
Beni S; Limtiaco JF; Larive CK
Anal Bioanal Chem; 2011 Jan; 399(2):527-39. PubMed ID: 20814668
[TBL] [Abstract][Full Text] [Related]
7. Combining (1)H NMR spectroscopy and chemometrics to identify heparin samples that may possess dermatan sulfate (DS) impurities or oversulfated chondroitin sulfate (OSCS) contaminants.
Zang Q; Keire DA; Wood RD; Buhse LF; Moore CM; Nasr M; Al-Hakim A; Trehy ML; Welsh WJ
J Pharm Biomed Anal; 2011 Apr; 54(5):1020-9. PubMed ID: 21215547
[TBL] [Abstract][Full Text] [Related]
8. Determination of impurities in heparin by capillary electrophoresis using high molarity phosphate buffers.
Wielgos T; Havel K; Ivanova N; Weinberger R
J Pharm Biomed Anal; 2009 Feb; 49(2):319-26. PubMed ID: 19155153
[TBL] [Abstract][Full Text] [Related]
9. Analysis of pharmaceutical heparins and potential contaminants using (1)H-NMR and PAGE.
Zhang Z; Li B; Suwan J; Zhang F; Wang Z; Liu H; Mulloy B; Linhardt RJ
J Pharm Sci; 2009 Nov; 98(11):4017-26. PubMed ID: 19642166
[TBL] [Abstract][Full Text] [Related]
10. Molecular profiling of heparinase-I resistant glycosaminoglycans in contaminated heparins. Comparative studies with uncontaminated heparin and porcine oversulfated chondroitin sulfate.
Clark M; Hoppensteadt D; Walenga J; Myers L; Cunanan J; Jeske W; Adiguzel C; Iqbal O; Fareed J
Int Angiol; 2008 Oct; 27(5):370-6. PubMed ID: 18974698
[TBL] [Abstract][Full Text] [Related]
11. Structure elucidation and biological activity of the oversulfated chondroitin sulfate contaminant in Baxter heparin.
McKee J; Bairstow S; Szabo C; Ray J; Wielgos T; Hu P; Chess E; Nordhaus M; Hai T; Campbell J; Donovan S; Viseux N; Riedel N; Cammack J; Johnson R
J Clin Pharmacol; 2010 Oct; 50(10):1159-70. PubMed ID: 20147614
[TBL] [Abstract][Full Text] [Related]
12. Identification of heparin samples that contain impurities or contaminants by chemometric pattern recognition analysis of proton NMR spectral data.
Zang Q; Keire DA; Buhse LF; Wood RD; Mital DP; Haque S; Srinivasan S; Moore CM; Nasr M; Al-Hakim A; Trehy ML; Welsh WJ
Anal Bioanal Chem; 2011 Aug; 401(3):939-55. PubMed ID: 21678118
[TBL] [Abstract][Full Text] [Related]
13. Heparin identification test and purity test for OSCS in heparin sodium and heparin calcium by weak anion-exchange high-performance liquid chromatography.
Hashii N; Kawasaki N; Itoh S; Qin Y; Fujita N; Hattori T; Miyata K; Bando A; Sekimoto Y; Hama T; Kashimura M; Tatsumi M; Mabuchi K; Namekawa H; Sakai T; Hirose M; Dobashi S; Shimahashi H; Koyama S; Herr SO; Kawai K; Yoden H; Yamaguchi T
Biologicals; 2010 Sep; 38(5):539-43. PubMed ID: 20452241
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and detection of N-sulfonated oversulfated chondroitin sulfate in marketplace heparin.
Mans DJ; Ye H; Dunn JD; Kolinski RE; Long DS; Phatak NL; Ghasriani H; Buhse LF; Kauffman JF; Keire DA
Anal Biochem; 2015 Dec; 490():52-4. PubMed ID: 26278168
[TBL] [Abstract][Full Text] [Related]
15. A robust method to quantify low molecular weight contaminants in heparin: detection of tris(2-n-butoxyethyl) phosphate.
Sassaki GL; Riter DS; Santana Filho AP; Guerrini M; Lima MA; Cosentino C; Souza LM; Cipriani TR; Rudd TR; Nader HB; Yates EA; Gorin PA; Torri G; Iacomini M
Analyst; 2011 Jun; 136(11):2330-8. PubMed ID: 21494716
[TBL] [Abstract][Full Text] [Related]
16. One-hour screening of adulterated heparin by simplified peroxide digestion and fast RPIP-LC-MS(2).
Li H; Wickramasekara S; Nemes P
Anal Chem; 2015 Aug; 87(16):8424-32. PubMed ID: 26168275
[TBL] [Abstract][Full Text] [Related]
17. Determination of oversulfated chondroitin sulfate and dermatan sulfate impurities in heparin by capillary electrophoresis.
Somsen GW; Tak YH; Toraño JS; Jongen PM; de Jong GJ
J Chromatogr A; 2009 May; 1216(18):4107-12. PubMed ID: 19272607
[TBL] [Abstract][Full Text] [Related]
18. Oversulfated chondroitin sulfate interaction with heparin-binding proteins: new insights into adverse reactions from contaminated heparins.
Li B; Suwan J; Martin JG; Zhang F; Zhang Z; Hoppensteadt D; Clark M; Fareed J; Linhardt RJ
Biochem Pharmacol; 2009 Aug; 78(3):292-300. PubMed ID: 19389385
[TBL] [Abstract][Full Text] [Related]
19. A nanosensor for ultrasensitive detection of oversulfated chondroitin sulfate contaminant in heparin.
Kalita M; Balivada S; Swarup VP; Mencio C; Raman K; Desai UR; Troyer D; Kuberan B
J Am Chem Soc; 2014 Jan; 136(2):554-7. PubMed ID: 24127748
[TBL] [Abstract][Full Text] [Related]
20. Interactions of oversulfated chondroitin sulfate (OSCS) from different sources with unfractionated heparin.
Gray A; Litinas E; Jeske W; Fareed J; Hoppensteadt D
Clin Appl Thromb Hemost; 2012; 18(2):166-73. PubMed ID: 22311630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
